Alfonso Soto

1.5k total citations
31 papers, 507 citations indexed

About

Alfonso Soto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Alfonso Soto has authored 31 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Alfonso Soto's work include Pituitary Gland Disorders and Treatments (15 papers), Growth Hormone and Insulin-like Growth Factors (10 papers) and Adrenal and Paraganglionic Tumors (8 papers). Alfonso Soto is often cited by papers focused on Pituitary Gland Disorders and Treatments (15 papers), Growth Hormone and Insulin-like Growth Factors (10 papers) and Adrenal and Paraganglionic Tumors (8 papers). Alfonso Soto collaborates with scholars based in Spain, United States and Italy. Alfonso Soto's co-authors include Alfonso Leal‐Cerro, Carlos Diéguez, Felipe F. Casanueva, Susan M. Webb, Elena Torres, Diego Bellido, Ignacio Bernabéu, Albert Lecube, Miguel Á. Japón and José A. Pintor‐Toro and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Endocrinology.

In The Last Decade

Alfonso Soto

30 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Soto Spain 13 333 131 97 85 74 31 507
S. Obradović Czechia 7 342 1.0× 86 0.7× 66 0.7× 52 0.6× 43 0.6× 9 455
Don Fleenor United States 9 242 0.7× 179 1.4× 133 1.4× 82 1.0× 125 1.7× 10 528
G Tamburrano Italy 13 370 1.1× 197 1.5× 153 1.6× 43 0.5× 65 0.9× 32 566
S Ciani Italy 6 321 1.0× 190 1.5× 127 1.3× 31 0.4× 45 0.6× 9 431
L. Bartolone Italy 10 315 0.9× 102 0.8× 74 0.8× 34 0.4× 39 0.5× 14 477
P. Beck-Peccoz Italy 10 394 1.2× 60 0.5× 41 0.4× 91 1.1× 41 0.6× 17 502
Sadeka Shahani United States 8 266 0.8× 53 0.4× 94 1.0× 17 0.2× 59 0.8× 9 524
Alfonso Leal Spain 7 301 0.9× 42 0.3× 59 0.6× 52 0.6× 49 0.7× 13 387
Camilla A M Glad Sweden 15 345 1.0× 88 0.7× 197 2.0× 63 0.7× 237 3.2× 27 691
E Vilardell Spain 11 268 0.8× 117 0.9× 113 1.2× 63 0.7× 109 1.5× 39 459

Countries citing papers authored by Alfonso Soto

Since Specialization
Citations

This map shows the geographic impact of Alfonso Soto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Soto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Soto more than expected).

Fields of papers citing papers by Alfonso Soto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Soto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Soto. The network helps show where Alfonso Soto may publish in the future.

Co-authorship network of co-authors of Alfonso Soto

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Soto. A scholar is included among the top collaborators of Alfonso Soto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Soto. Alfonso Soto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araujo‐Castro, Marta, Javier Aller, Mónica Marazuela, et al.. (2025). Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinología Diabetes y Nutrición. 72(10). 501654–501654. 1 indexed citations
2.
Lamas, Cristina, Rosa Cámara, Carmen Fajardo, et al.. (2023). Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. Frontiers in Endocrinology. 14. 1204206–1204206. 7 indexed citations
3.
Morales, Cristóbal, et al.. (2022). Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study. Drugs in Context. 11. 1–9. 1 indexed citations
4.
Morales, Cristóbal, Virginia Bellido, Cristina Tejera Pérez, et al.. (2021). DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain. Journal of Comparative Effectiveness Research. 10(10). 815–821. 2 indexed citations
5.
López‐Cano, Carolina, Andreea Ciudin, Enric Sánchez, et al.. (2021). Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study. Diabetes. 71(2). 315–320. 24 indexed citations
6.
Gómez‐Peralta, Fernando, Cristina Abreu, Albert Lecube, et al.. (2017). Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes. Diabetes Therapy. 8(5). 953–962. 35 indexed citations
7.
Puig‐Domingo, Manel, Alfonso Soto, Eva Venegas, et al.. (2016). Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study. Endocrinología y Nutrición. 63(8). 397–408. 20 indexed citations
8.
Puig‐Domingo, Manel, Alfonso Soto, Eva Venegas, et al.. (2016). Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study. Endocrinología y Nutrición (English Edition). 63(8). 397–408. 3 indexed citations
9.
Díaz‐Rodriguez, Esther, Alejandro Ibáñez‐Costa, Montserrat García-Lavandeira, et al.. (2014). Somatotropinomas, But Not Nonfunctioning Pituitary Adenomas, Maintain a Functional Apoptotic RET/Pit1/ARF/p53 Pathway That Is Blocked by Excess GDNF. Endocrinology. 155(11). 4329–4340. 11 indexed citations
10.
Sesmilo, Gemma, Eugenia Resmini, Ignacio Bernabéu, et al.. (2014). Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre S panish study. Clinical Endocrinology. 81(6). 883–890. 17 indexed citations
11.
12.
Bellido, Diego, Martin Lange, José M. Carreira, et al.. (2013). Índices antropométricos estimadores de la distribución adiposa abdominal y capacidad discriminante para el síndrome metabólico en población española. Clínica e Investigación en Arteriosclerosis. 25(3). 105–109. 7 indexed citations
13.
Sesmilo, Gemma, Sonia Gaztambide, Eva Venegas, et al.. (2012). Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary. 16(1). 115–121. 55 indexed citations
14.
Roset, Montse, Manuel Luque‐Ramírez, Susan M. Webb, et al.. (2012). Cost of Clinical Management of Acromegaly in Spain. Clinical Drug Investigation. 32(4). 235–245. 28 indexed citations
15.
Martínez‐Fuentes, Antonio J., Rafael Vázquez-Martı́nez, Manuel D. Gahete, et al.. (2010). Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. European Journal of Endocrinology. 164(3). 355–362. 27 indexed citations
16.
Soto, Alfonso, et al.. (2009). Inyección retrobulbar de triamcinolona y control glucémico. Archivos de la Sociedad Española de Oftalmología. 84(12). 599–603. 3 indexed citations
17.
Sáez, Carmen, Carolina Castilla, Alfonso Soto, et al.. (2006). Prognostic Significance of Human Pituitary Tumor-Transforming Gene Immunohistochemical Expression in Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1404–1409. 42 indexed citations
18.
Leal‐Cerro, Alfonso, Elena Torres, Alfonso Soto, et al.. (2002). Ghrelin Is No Longer Able to Stimulate Growth Hormone Secretion in Patients with Cushing’s Syndrome but Instead Induces Exaggerated Corticotropin and Cortisol Responses. Neuroendocrinology. 76(6). 390–396. 40 indexed citations
19.
Leal‐Cerro, Alfonso, et al.. (2002). Effect of withdrawal of somatostatin plus growth hormone (GH)‐releasing hormone as a stimulus of GH secretion in Cushing's syndrome. Clinical Endocrinology. 57(6). 745–749. 12 indexed citations
20.
Leal‐Cerro, Alfonso, et al.. (2001). Influence of Cortisol Status on Leptin Secretion. Pituitary. 4(1-2). 111–116. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Obradović Breakdown of academic impact, for papers by Don Fleenor Breakdown of academic impact, for papers by G Tamburrano Breakdown of academic impact, for papers by S Ciani Breakdown of academic impact, for papers by L. Bartolone Breakdown of academic impact, for papers by P. Beck-Peccoz Breakdown of academic impact, for papers by Sadeka Shahani Breakdown of academic impact, for papers by Alfonso Leal Breakdown of academic impact, for papers by Camilla A M Glad Breakdown of academic impact, for papers by E Vilardell
Rankless by CCL
2026